%PDF-1.4
%
115 0 obj
<>
endobj
114 0 obj
<>stream
2017-01-26T18:15:14+05:30
Arbortext Advanced Print Publisher 9.1.510/W Unicode
2017-03-22T06:31:06-07:00
2017-03-22T06:31:06-07:00
Acrobat Distiller 10.0.0 (Windows)
application/pdf
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
uuid:56ae0bee-e105-4f82-b08f-c4896abf65ac
uuid:40e241b9-1dd2-11b2-0a00-af00b8089aff
endstream
endobj
111 0 obj
<>
endobj
2 0 obj
<>
endobj
113 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 110 0 R/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 3 0 R/Type/Page>>
endobj
21 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 22 0 R/Type/Page>>
endobj
40 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 41 0 R/Type/Page>>
endobj
50 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
65 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 66 0 R/Type/Page>>
endobj
69 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 70 0 R/Type/Page>>
endobj
77 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 78 0 R/Type/Page>>
endobj
85 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 86 0 R/Type/Page>>
endobj
162 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
202 0 obj
[206 0 R 207 0 R 208 0 R 209 0 R 210 0 R 211 0 R 212 0 R 213 0 R 214 0 R 215 0 R 216 0 R]
endobj
203 0 obj
<>stream
q
184.8032227 0 0 46.2008057 72 663.7991943 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 262 659.99988 Tm
(online December 8, 2016)Tj
15.62098 1 Td
( originally published)Tj
/T1_1 1 Tf
-15.62098 0 Td
(doi:10.1182/blood-2016-09-742205)Tj
0 1.00001 TD
(2017\240129: 846-854)Tj
/T1_0 1 Tf
0 1 TD
(\240)Tj
T*
(\240)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 72 551.99976 Tm
(Fran\347ois-Xavier Mahon and for the France Intergroupe des Leuc\351mies\
My\351lo\357des Chroniques)Tj
T*
(Aude Charbonnier, Hyacinthe Johnson-Ansah, Marie-Pierre Noel, Philippe R\
ousselot, )Tj
0 1.00001 TD
(Etienne, Jean-Michel Pignon, Bruno Villemagne, Martine Escoffre-Barbe, J\
ean-Christophe Ianotto,)Tj
0 1 TD
(Guerci-Bresler, Martine Gardembas, Val\351rie Coiteux, Gaelle Guillerm, \
Laurence Legros, Gabriel )Tj
T*
(Delphine Rea, Franck E. Nicolini, Michel Tulliez, Fran\347ois Guilhot, J\
oelle Guilhot, Agn\350s)Tj
0 1.00001 TD
(\240)Tj
/T1_2 1 Tf
13 0 0 13 72 611.99994 Tm
(interim analysis of the STOP 2G-TKI study)Tj
0 1 TD
(Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia:)Tj
/T1_1 1 Tf
T*
(\240)Tj
ET
72 518 m
521 518 l
0 0 m
S
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 493.99994 Tm
(http://www.bloodjournal.org/content/129/7/846.full.html)Tj
0 g
/T1_1 1 Tf
T*
(Updated information and services can be found at:)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 163.68997 449.99991 Tm
( \(1634 articles\))Tj
0 0 1 rg
-8.16899 0 Td
(Myeloid Neoplasia)Tj
0 g
/T1_0 1 Tf
-1.00001 0 Td
(\240\240\240 )Tj
/T1_1 1 Tf
11.16898 1 Td
( \(4382 articles\))Tj
0 0 1 rg
-10.16897 0 Td
(Free Research Articles)Tj
0 g
/T1_0 1 Tf
-1.00001 0 Td
(\240\240\240 )Tj
/T1_1 1 Tf
15.05898 1.00001 Td
( \(4502 articles\))Tj
0 0 1 rg
-14.05897 0 Td
(Clinical Trials and Observations)Tj
0 g
/T1_0 1 Tf
-1.00001 0 Td
(\240\240\240 )Tj
/T1_1 1 Tf
T*
(Articles on similar topics can be found in the following Blood collectio\
ns)Tj
ET
72 433 m
521 433 l
0 0 m
S
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 408.99994 Tm
(http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests)Tj
0 g
/T1_1 1 Tf
T*
(Information about reproducing this article in parts or in its entirety m\
ay be found online at:)Tj
ET
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 370.99997 Tm
(http://www.bloodjournal.org/site/misc/rights.xhtml#reprints)Tj
0 g
/T1_1 1 Tf
T*
(Information about ordering reprints may be found online at:)Tj
ET
BT
0 0 1 rg
/T1_2 1 Tf
10 0 0 10 72 332.99997 Tm
(http://www.bloodjournal.org/site/subscriptions/index.xhtml)Tj
0 g
/T1_1 1 Tf
T*
(Information about subscriptions and ASH membership may be found online a\
t:)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
10 0 0 10 72 41.99991 Tm
(\240 )Tj
T*
(Copyright 2011 by The American Society of Hematology; all rights reserve\
d.)Tj
0 g
0 1.00001 TD
(of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036.)Tj
0 1 TD
(Blood \(print ISSN 0006-4971, online ISSN 1528-0020\), is published week\
ly by the American Society)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
9 0 0 9 351.27777 766 Tm
(For personal use only.)Tj
0 g
-8.89398 0 Td
(on March 22, 2017. )Tj
-4.058 0 Td
(by guest )Tj
/T1_0 1 Tf
8 0 0 8 232.71002 766 Tm
( )Tj
0 0 1 rg
/T1_1 1 Tf
9 0 0 9 146.18417 766 Tm
(www.bloodjournal.org)Tj
0 g
-2.61097 0 Td
(From )Tj
ET
endstream
endobj
205 0 obj
<>/Filter/FlateDecode/Height 132/Length 26933/Name/X/Subtype/Image/Type/XObject/Width 528>>stream
H TW &Ȣ`A"
B$.cmZw-VBE[uZV
jq!Iqc7}D ! a $d|S&' pB+4d2Fgc9`
hzlڹKX]]īͷ`*T>P+/%[2qgGCCfHY$rlIq'XL*T>\
^1)"z70l./dr`&<{+N`DGx%fz q̇N~Wz
.SBy
tƚ?ژSB
Շ"B&#)\iGzqUKIO VvqKs
6;o;|?R
̼445폟ҳ9Y V[}lPB5%e%UDFΘ#lmT:^$ftuvJ!Dr%+pT]qvSzEgSų}7B7|0I$2|PBKĝ/&Ź 擇o1AL*u,olr^T<ŘDFGST:Aܺ}⦭ʳk?`22{fyY+Lh]۱?m6rFhjkTC_mԚ(輠vLjrY)u E
+ר;/T"(x
hwna8_f0% q'8:Ymn0Y~
:VӪ HݸN.pCky=64p`7qy>֛